SavedAdd your journal

Journals / MN Kardiyoloji / 2009 / Cilt: 16 - Sayı: 2

Utilization of homograft valves in heart valve diseases

Kalp kapak hastalıklarında homogreftler

Yeşim GÜRAY
Ümit GÜRAY
Şule KORKMAZ
Pages
141–145
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The decision for the type the prosthetic valve should be individualized according to the patient and disease.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Valvular heart disease is still an impoartant reason of mortality and morbidity.
📊
Key Findings & Data:Homografts have been used for the replacement of aortic valve for over 30 years.
💡
Conclusion & Impact:The decision for the type the prosthetic valve should be individualized according to the patient and disease.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Biyoprotezler · Kalp kapağı hastalıkları · Nakil

Abstract

Valvular heart disease is still an impoartant reason of mortality and morbidity. Homografts have been used for the replacement of aortic valve for over 30 years. They provide a better hemodynamic profile with low transvalvular gradients. Lifelong anticoagulation is not needed because they are associated with low tromboembolic risk and also they are resistant to prosthetic valve endocarditis. The decision for the type the prosthetic valve should be individualized according to the patient and disease.

Özet

Kalp kapak hastalıkları halen tüm dünyada önemli mortalite ve morbidite nedenidir. Biyoprotez kapaklardan homogreftler, özellikle aort kapak replasmanında 30 yılı aşan bir süredir kullanılmaktadır. Düşük transvalvüler gradiyent ile birlikte diğer kapaklardan daha iyi hemodinamik profil, düşük tromboemboli riski ve ömür boyu antikoagülan kullanımına gereksinim duyulmaması, prostatik kapak enfeksiyonuna dirençli olmaları homogreftlerin önemli avantajlarıdır. Hastaya ne tür kapak kullanılacağına hastaya ve hastalığa göre karar verilmelidir.

🔖

Cite This Article

GÜRAY, Y., GÜRAY, Ü., KORKMAZ, Ş. (2009). Utilization of homograft valves in heart valve diseases. MN Kardiyoloji, Cilt: 16 - Sayı: 2, 141–145. https://ajindex.com/articles/299096

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. American Heart Association (2002) Heart Disease and Stroke Statistics-2003
  2. Update Dallas, Texas: American Heart Association. 2.Rabkin E, Schoen FJ. Cardiovascular tissue engineering. Cardiovasc Pathol 2002;ll:305-17. 3.Hufnagel CA, Harvey WP, Rabil PJ; McDermottTF. Surgical correction of aortic insufficiency Surgery 1954;35:673-83. 4.Vongpatanasin W, Hillis LD, Lange RA. Prosthetic heart valves. N Engl J Med 1996;335: 407-16. 5.Bonow RO, Carabello BA, Chatterjee K et al. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiog-raphy and Interventions, and Society of Thoracic Sur-geons.J Am Coll Cardiol. 2008;52:el-142. 6.Butany J, Ahluwalia MS, Munroe C et al. Mechanical heart valve prostheses: identification and evaluation. Cardiovasc Pathol. 2003;12:322-44. 7.Turpie AG, Gent M, Laupacis A et al. A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement. N Engl J Med.l993;329:524-9. 8.Fann Jl, Miller DC, Moore KA et al. Twenty-year clinical experience with porcine bioprostheses. Ann Thorac Surg. 1996;62:1301-ll. 9.Cohn LH,Lipson W. Selection and complications of cardiac valvular protheses.ln: Baue AE,Geha AS,Hammond GL, Laks H,Naunheim KS,editors.Glenn's Thoracic and Cardiovascular Surgery. Vol 2. 6th ed. Stamford (CT): Appleton &Lange;1996;2043-55. 10.Butany J, Fayet C, Ahluwalia MS et al. Biological replacement heart valves.Identification and evaluation. Cardiovasc Pathol. 2003;12:119-39. 11.Bloomfield P. Choice of heart valve prosthesis. Heart. 2002;87:583-9. 12.O'Brien MF. Homografts and autografts. In: Baue AE, Geha AS, Hammond GL, Laks H, Naunheim KS, editors. Glenn's Thoracic and Cardiovascular Surgery. Vol 2. 6th ed. Stamford (CT): Appleton& Lange; 1996;2005-42. 13.Ross DN. Replacement of aortic and mitral valves with a pulmonary autograft. Lancet. 1967;2:956-8. 14.O'Brien MF, Stafford EG, Gardner MA, Pohlner PG, McGiffin DC. A comparison of aortic valve replacement with viable cryopreserved and fresh allograft valves, with a note on chromosomal studies. J Thorac Cardiovasc Surg. 1987;94:812-23. 15.Hampton CR, Chong AJ, Verrie